DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1195575
Title:
Development of a Novel AAV Vector Capsid Optimized for OA Gene Therapy
Report Date:
2022-09-01
Abstract:
Osteoarthritis (OA) is a chronic, degenerative, often crippling disease that primarily affects large weight-bearing joints. OA is most commonly linked to wear and tear of the joints from old age. In younger people, though, it arises from a significant joint injury, one that damages the bones and cartilage (post-traumatic osteoarthritis; PTOA). Indeed, OA one of the primary causes of disability among active duty soldiers and veterans. Despite the constant claims in the media, there is no drug or dietary supplement capable of slowing joint destruction in OA and although some drugs can ease OA joint pain, they can't stop the erosive biological processes.
Document Type:
Conference:
Journal:
Pages:
20
File Size:
0.98MB
W81XWH-19-1-0515, 12712000
(W81XWH1910515, 12712000);
Contracts:
Grants:
Distribution Statement:
Approved For Public Release
